Medical Cost Trend: Measuring Health-Care Cost Growth

Medical cost trend describes the rate at which health-care costs rise for a comparable covered population over time.

A simplified analytical form is:

1Medical Cost Trend
2≈ Change in Cost per Comparable Member

The exact methodology is issuer-specific. Some companies discuss a single consolidated trend estimate, while others separate inpatient, outpatient, physician, pharmacy, Medicare, commercial, or Medicaid trends.

Trend is not simply total medical-cost growth

Total medical expense can rise because the insurer covers more members. Medical cost trend instead tries to isolate the change in cost intensity for a comparable population.

A useful decomposition is:

1Total Medical Cost Growth
2≈ Membership Growth
3+ Cost Trend
4+ Mix / Acquisitions / Other Effects

If membership grows 8% and total medical costs grow 15%, it does not follow automatically that medical cost trend was 7%. Product mix, member risk, seasonality, acquisitions, reserve development, and accounting changes can break that simple bridge.

Utilization and unit cost are core drivers

Medical cost trend is commonly driven by a combination of:

• utilization frequency;
• provider reimbursement rates;
• service intensity and site of care;
• procedure and diagnosis mix;
• specialty drug and pharmacy inflation;
• coding intensity;
• member acuity and risk mix; and
• benefit-design changes.

That means a higher trend can come from members using more services, the same services becoming more expensive, or the mix shifting toward more intensive care.

Pricing must catch up with cost trend

Managed-care underwriting depends on pricing premiums to cover expected claims and administrative costs.

If premium yield rises more slowly than underlying medical trend, Medical Loss Ratio can deteriorate. If pricing, benefit changes, network actions, or care management more than offset trend, the ratio can improve.

The timing matters because many premiums are set prospectively while claims emerge later.

Medical trend is not the same as pharmacy trend

Issuers sometimes discuss medical and pharmacy trends separately because prescription-drug costs can behave differently from facility and physician claims.

Humana's 2026 disclosures, for example, discuss medical and pharmacy trend together while also noting pharmacy cost trend can outpace medical trend. Analysts should preserve the issuer's scope instead of combining components automatically.

Reported trend can be expected or observed

Management may discuss:

• pricing assumptions for future trend;
• current observed utilization;
• incurred claims experience;
• completed claims experience; or
• updated full-year expectations.

These are not interchangeable. A forward pricing assumption is a forecast; an incurred-cost trend is an estimate based on claims and reserves; completed-claim trend is more mature but arrives with delay.

A simple example

Suppose a comparable member cohort generated $500 PMPM of medical cost last year and $535 PMPM this year:

1($535 - $500) ÷ $500 = 7.0%

That 7% illustrates medical cost trend for the defined cohort and cost basis. It does not say total company medical expense grew 7%.

Filing examples

UnitedHealth Group's Q2 2026 Form 10-Q discusses medical cost trend remaining above historical levels and cites provider reimbursement, service intensity, and coding intensity among the drivers.

Humana's Q2 2026 prepared remarks state that medical and pharmacy cost trends were running in line with expectations and discuss the relationship between pricing, benefits, membership mix, and trend. Elevance Health states that premium-rate increases reflect, among other factors, medical cost trends.

Sources:

• UnitedHealth Group Q2 2026 Form 10-Q
• Humana Q2 2026 prepared remarks
• Elevance Health Q2 2026 Form 10-Q

Bottom line

Medical cost trend measures cost growth for a defined insured population, not total medical-expense growth. Preserve product, geography, utilization basis, provider-price effects, pharmacy treatment, risk mix, reserve maturity, and expected-versus-observed status before comparing trend across health insurers.

Explore more topics in the Financial Research Encyclopedia.